Invicta Diagnostic Board to Consider Half-Year Results and Nashik Diagnostic Acquisition
Invicta Diagnostic Ltd 路 Intimation 路 14 Nov 2026, 5:30 am
Invicta Diagnostic Board to Consider Half-Year Results and Nashik Diagnostic Acquisition Invicta Diagnostic Limited has scheduled a Board of Directors meeting for 14th Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the half year ended 30th Sep'26. Additionally, the board will evaluate a proposal to acquire existing diagnostic centre businesses in Nashik through a slump sale via a subsidiary to expand its operational footprint. The trading window for designated persons has been closed since 1st Oct'26 and will reopen 48 hours post the declaration of the financial results.
Original exchange filing (PDF)
More announcements from Invicta Diagnostic Ltd
- Invicta Diagnostic Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 15 Nov 2026
- Invicta Diagnostic Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 15 Nov 2026
- INVICTA DIAGNOSTIC LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 14 Nov 2026
- Invicta Diagnostic Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 19, 2026. Further, the company has informed the Exchange regarding voting results. 路 20 Sept 2026
- Invicta Diagnostic Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 19, 2026 路 20 Sept 2026
- Invicta Diagnostic Limited has informed the Exchange regarding Outcome of Board Meeting held on September 18, 2026 wherein Board considered and approved the proposed business outlook and forward-looking guidance to be communicated by the Chairman & Managing Director and Chief Financial Officer to the Members at the Company s 3rd Annual General Meeting scheduled to be held on Saturday, 19th September, 2026. 路 18 Sept 2026
- Invicta Diagnostic Limited has informed the Exchange about Commencement of commercial operations of Centres at Shegaon Diagnostic LLP (a Subsidiary LLP), and Porteus Pathogenius LLP (a Step-Down Subsidiary LLP) 路 17 Sept 2026
- Invicta Diagnostic Limited has informed the Exchange about Copy of Newspaper Publication of AGM Notice 路 28 Aug 2026
